Literature DB >> 12801236

Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth.

Chengxin Zhi1, Zheng-Yu Long, Joseph Gambino, Wei-Chu Xu, Neal C Brown, Marjorie Barnes, Michelle Butler, William LaMarr, George E Wright.   

Abstract

Certain substituted 6-anilinouracils are potent and selective inhibitors of Gram+ bacterial DNA polymerase IIIC (pol IIIC). In addition, analogues with 3-substituents in the uracil ring have potent antibacterial activity against Gram+ organisms in culture. In an attempt to find optimal anilino substituents for pol IIIC binding and optimal 3-substituents for antibacterial activity, we have prepared several series of 3-substituted-6-aminouracils and assayed their activity against pol IIIC from Bacillus subtilis and a panel of Gram+ and Gram- bacteria in culture. The 6-(3-ethyl-4-methylanilino) group and closely related substituent patterns maximized pol IIIC inhibition potency. Among a series of 3-(substituted-butyl)-6-(3-ethyl-4-methylanilino)uracils, basic amino substituents increased pol IIIC inhibition, but decreased antibacterial activity. The most potent antibacterials were simple hydroxybutyl and methoxybutyl derivatives, and hydrophobically substituted piperidinylbutyl derivatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801236     DOI: 10.1021/jm020591z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Diversity-oriented, one-pot, multi-component synthesis of substituted uracil derivatives.

Authors:  Yogesh Y Pedgaonkar; Mariam S Degani; Radhakrishnan P Iyer
Journal:  Mol Divers       Date:  2010-08-20       Impact factor: 2.943

2.  Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.

Authors:  Chengxin Zhi; Zheng-Yu Long; Andrzej Manikowski; Jeanne Comstock; Wei-Chu Xu; Neal C Brown; Paul M Tarantino; Karsten A Holm; Edward J Dix; George E Wright; Marjorie H Barnes; Michelle M Butler; Kimberly A Foster; William A LaMarr; Benoit Bachand; Richard Bethell; Caroline Cadilhac; Sylvie Charron; Serge Lamothe; Irina Motorina; Richard Storer
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

3.  Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.

Authors:  Alexander Kuhl; Niels Svenstrup; Christoph Ladel; Michael Otteneder; Annegret Binas; Guido Schiffer; Michael Brands; Thomas Lampe; Karl Ziegelbauer; Helga Rübsamen-Waigmann; Dieter Haebich; Kerstin Ehlert
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.

Authors:  Wei-Chu Xu; George E Wright; Neal C Brown; Zheng-Yu Long; Cheng-Xin Zhi; Sofya Dvoskin; Joseph J Gambino; Marjorie H Barnes; Michelle M Butler
Journal:  Bioorg Med Chem Lett       Date:  2011-05-30       Impact factor: 2.823

5.  Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.

Authors:  Michelle M Butler; William A Lamarr; Kimberly A Foster; Marjorie H Barnes; Donna J Skow; Patrick T Lyden; Lauren M Kustigian; Chengxin Zhi; Neal C Brown; George E Wright; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

6.  Clostridium difficile DNA polymerase IIIC: basis for activity of antibacterial compounds.

Authors:  Andrea Torti; Andrea Lossani; Lida Savi; Federico Focher; George Edward Wright; Neal Curtis Brown; Wei-Chu Xu
Journal:  Curr Enzym Inhib       Date:  2011-10

7.  Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity.

Authors:  Dianqing Sun; Michael S Scherman; Victoria Jones; Julian G Hurdle; Lisa K Woolhiser; Susan E Knudson; Anne J Lenaerts; Richard A Slayden; Michael R McNeil; Richard E Lee
Journal:  Bioorg Med Chem       Date:  2009-04-09       Impact factor: 3.641

8.  Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.

Authors:  Daniel Aiello; Marjorie H Barnes; Esther E Biswas; Subhasis B Biswas; Shen Gu; John D Williams; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem       Date:  2009-05-12       Impact factor: 3.641

Review 9.  DNA Replication in Mycobacterium tuberculosis.

Authors:  Zanele Ditse; Meindert H Lamers; Digby F Warner
Journal:  Microbiol Spectr       Date:  2017-03

Review 10.  Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.

Authors:  Andrew Robinson; Rebecca J Causer; Nicholas E Dixon
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.